Halozyme (HALO) Debt/EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 0.20 0.49 3.62 3.68 2.75   2.08  
Changes by years, y/y, % -27% +143% +636% +2% -25%     -3.5%

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, %

Halozyme (HALO) Debt/EBITDA US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
Debt/EBITDA 3.03 2.71 2.79 2.32 2.08   2.08
Changes by years, y/y, % -25% -36% -23% -41% -32%    
Changes by quarters, q/q, % -23% -11% +3% -17% -10%    

Halozyme. Debt/EBITDA

Halozyme. Debt/EBITDA, changes, y/y, %

Halozyme. Debt/EBITDA, changes, q/q, %